Medicare Enrolled
Dr. Christopher Ho, M.D.
Hematology & Oncology · West Hills, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ho from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ho?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ho
Dr. Christopher Ho is a hematology & oncology specialist in West Hills, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Ho performed 67,533 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ho received a total of $78,070 from 72 pharmaceutical and/or device companies across 771 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ho is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 11% volume in CA
$78,070 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗67,533
Medicare services
Top 11% in CA for hematology & oncology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
21,420 | $0 | $1 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
18,750 | $1 | $2 |
| Denosumab injection (Prolia/Xgeva) | 7,462 | $18 | $46 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,614 | $0 | $0 |
| Iron infusion (Monoferric) | 2,600 | $16 | $45 |
| Anti-nausea injection (ondansetron/Zofran) | 2,536 | $0 | $0 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,816 | $8 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,290 | $109 | $283 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,249 | $10 | $21 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,038 | $6 | $6 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
525 | $74 | $202 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
510 | $27 | $70 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
489 | $9 | $19 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
477 | $102 | $219 |
| Iron level test | 399 | $6 | $13 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
397 | $9 | $17 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
389 | $13 | $27 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
365 | $13 | $32 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
348 | $123 | $324 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
271 | $68 | $179 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
223 | $14 | $29 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
221 | $147 | $422 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
215 | $16 | $32 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
213 | $68 | $152 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
201 | $0 | $2 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
193 | $15 | $30 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
179 | $59 | $159 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
143 | $61 | $157 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
126 | $19 | $38 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
117 | $136 | $368 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
111 | $26 | $68 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
94 | $179 | $462 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
86 | $5 | $10 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
81 | $150 | $397 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 76 | $20 | $42 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
58 | $14 | $37 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
53 | $1 | $2 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
51 | $7 | $13 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
39 | $16 | $34 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
37 | $83 | $242 |
| Bone marrow aspiration A procedure to remove a small sample of liquid bone marrow for diagnostic testing. |
25 | $72 | $364 |
| Biopsy of bone marrow | 25 | $146 | $379 |
| Blood smear interpretation with written report A physician examines a blood sample slide under a microscope to analyze blood cells. The doctor provides a written report of their findings. |
21 | $21 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
65.1% high complexity
20.0% medium
14.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$78,070
Total received (2018-2024)
Avg $11,153/year across 7 years
Top 10% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
771
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,560
2023
$9,122
2022
$13,343
2021
$20,493
2020
$8,133
2019
$19,614
2018
$1,805
Payments by company (2024)
PFIZER INC.
$3,175
Janssen Biotech, Inc.
$219
AstraZeneca Pharmaceuticals LP
$163
Merck Sharp & Dohme LLC
$154
Astellas Pharma US Inc
$153
Blueprint Medicines Corporation
$148
Genentech USA, Inc.
$125
Celgene Corporation
$109
Incyte Corporation
$103
Gilead Sciences, Inc.
$100
E.R. Squibb & Sons, L.L.C.
$89
ABBVIE INC.
$74
Regeneron Healthcare Solutions, Inc.
$69
Karyopharm Therapeutics Inc.
$61
Eisai Inc.
$59
PharmaEssentia USA Corporation
$57
TAIHO ONCOLOGY, INC.
$56
EMD Serono, Inc.
$56
JAZZ PHARMACEUTICALS INC.
$52
Daiichi Sankyo Inc.
$51
Lilly USA, LLC
$50
Bayer Healthcare Pharmaceuticals Inc.
$45
Novartis Pharmaceuticals Corporation
$43
Octapharma USA, Inc.
$38
ARRAY BIOPHARMA INC
$31
Ipsen Biopharmaceuticals, Inc
$30
Tempus AI, Inc
$27
Legend Biotech USA Inc.
$25
ADC Therapeutics America, Inc.
$25
SOBI, INC
$24
GlaxoSmithKline, LLC.
$23
Novocure Inc.
$22
BeiGene USA, Inc.
$21
MorphoSys, US Inc.
$20
Helsinn Therapeutics (U.S.), Inc.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$16
Agios Pharmaceuticals, Inc.
$15
Cranial Technologies, Inc
$14
Top 3 companies account for 64.0% of 2024 payments
All-time payments by company (2018-2024) ›
Foundation Medicine, Inc.
$38,651
AstraZeneca Pharmaceuticals LP
$17,387
PFIZER INC.
$5,288
EMD Serono, Inc.
$2,340
E.R. Squibb & Sons, L.L.C.
$2,144
Blueprint Medicines Corporation
$1,284
Genentech USA, Inc.
$989
Incyte Corporation
$748
Novartis Pharmaceuticals Corporation
$732
Janssen Biotech, Inc.
$501
GENZYME CORPORATION
$485
Lilly USA, LLC
$481
Amgen Inc.
$440
Merck Sharp & Dohme LLC
$401
Astellas Pharma US Inc
$369
Boehringer Ingelheim Pharmaceuticals, Inc.
$322
Celgene Corporation
$315
Karyopharm Therapeutics Inc.
$312
Merck Sharp & Dohme Corporation
$312
GlaxoSmithKline, LLC.
$309
Bayer HealthCare Pharmaceuticals Inc.
$267
Gilead Sciences, Inc.
$226
Alexion Pharmaceuticals, Inc.
$199
Seagen Inc.
$195
Dendreon Pharmaceuticals LLC
$195
Eisai Inc.
$194
Exelixis Inc.
$177
Regeneron Healthcare Solutions, Inc.
$166
Daiichi Sankyo Inc.
$161
Bayer Healthcare Pharmaceuticals Inc.
$152
Takeda Pharmaceuticals U.S.A., Inc.
$148
EISAI INC.
$132
Blue Earth Diagnostics Limited
$129
Helsinn Therapeutics (U.S.), Inc.
$128
ADC Therapeutics America, Inc.
$119
ABBVIE INC.
$104
TESARO, Inc.
$100
Ipsen Biopharmaceuticals, Inc
$98
Seattle Genetics, Inc.
$97
MorphoSys, US Inc.
$94
TerSera Therapeutics LLC
$93
TAIHO ONCOLOGY, INC.
$88
AVEO Pharmaceuticals, Inc.
$88
Stemline Therapeutics Inc.
$68
INSYS Therapeutics Inc
$68
MEDIVATION FIELD SOLUTIONS LLC
$67
PharmaEssentia USA Corporation
$57
JAZZ PHARMACEUTICALS INC.
$52
Deciphera Pharmaceuticals Inc.
$48
TOLMAR Pharmaceuticals, Inc.
$45
BeiGene USA, Inc.
$43
Octapharma USA, Inc.
$38
Kite Pharma, Inc.
$31
ARRAY BIOPHARMA INC
$31
Tempus AI, Inc
$27
Global Blood Therapeutics, Inc.
$26
Legend Biotech USA Inc.
$25
SOBI, INC
$24
Spectrum Pharmaceuticals Inc.
$24
Mirati Therapeutics, Inc.
$24
SANOFI-AVENTIS U.S. LLC
$23
CSL Behring
$23
CTI BioPharma Corp.
$22
Novocure Inc.
$22
Rigel Pharmaceuticals, Inc.
$21
PUMA BIOTECHNOLOGY, INC.
$19
Secura Bio, Inc.
$17
Agios Pharmaceuticals, Inc.
$15
Cranial Technologies, Inc
$14
Puma Biotechnology, Inc.
$13
Shire North American Group Inc
$12
Boston Scientific Corporation
$12
Top 3 companies account for 78.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALOXI · AYVAKIT · Alecensa · Avastin · Axumin · BAVENCIO · BESPONSA · BESREMI · BOSULIF · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CAMZYOS · CARVYKTI · CERDELGA · CYRAMZA · Cabometyx · DARZALEX · DUPIXENT · Doc Band · ELELYSO · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ERLEADA · EVENITY · Enhertu · FARYDAK · FASLODEX · FOTIVDA · FOUNDATIONACT · FOUNDATIONONE · FOUNDATIONONE CDX · FOUNDATIONONE LIQUID · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · GILOTRIF · General - Pain Management · Hizentra · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · Otezla · PEMAZYRE · PIQRAY · PROMACTA · PROVENGE · PYRUKYND · Pomalyst · QINLOCK · REBLOZYL · RETACRIT · RYBREVANT · RYDAPT · Revlimid · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TEPMETKO · TUKYSA · Tavalisse · Tecentriq · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VPRIV · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XGEVA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · ZEJULA · ZEPOSIA · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
251
County median income
$87,760
Nearest hospital to ZIP centroid (approximate)
UCLA WEST VALLEY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ho is a mixed practice specialist, with above-average Medicare volume (top 11% in CA), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ho experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Ho performed 21,420 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ho receive payments from pharmaceutical companies?
Yes. Dr. Ho received a total of $78,070 from 72 companies across 771 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ho's costs compare to other hematology & oncology specialists in West Hills?
Dr. Ho's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ho) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in West Hills
Browse hematology & oncology specialists in West Hills ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Foundation Medicine, Inc. Payments to Doctors
See all physicians who received payments from Foundation Medicine, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology